Germany-headquartered CNS drug specialist Neuraxpharm today revealed that UK health technology assessor the National ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, today announces that the National Institute for ...

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Trastuzumab deruxtecan is a targeted drug used to treat certain types of cancer: breast cancer, gastric or gastroesophageal ...

The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products ...

The Food and Drug Administration (FDA) has expanded the list of medicines exempted from value-added tax (VAT) to ensure ...

In the infusion area, volunteers offer a snack or beverage to a patient ... By giving patients peace of mind in knowing that their bills are being paid while they are undergoing treatment, the FCS ...

These new findings build on earlier research on light-linking solutions to improve infusion patient safety, which can be found in an article entitled “Untangling Infusion Confusion: A Comparative ...

The Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval of additional indication of US-based Bristol-Myers Squibb's anti-cancer drug ...

Gohibic will be available in the form of a 200 mg concentrate for solution for infusion. The committee specified that injection with Gohibic should be initiated and monitored by a physician ...

“This year, Starbucks is debuting the new Starbucks Vanilla and Chocolate Cold Brew Concentrate, Starbucks Non-dairy Sugar Cookie Latte Creamer and the Starbucks Peppermint Mocha Flavored ...